Database reach, site capability, and investigator availability are assessed in the first pass.
How ARI Works
From first inquiry to close-out, ARI keeps the study path clear.
ARI manages the full study lifecycle from sponsor inquiry through feasibility, startup, conduct, and close-out, with defined milestones and clear sponsor communication at every stage.
Leadership-direct inquiry review
Structured startup milestones
2–4 week typical activation
Sponsor operations view
IRB or ethics submission, staff training, system access, and supply verification, all with defined milestones.
Enrollment reporting, query resolution, and issue management throughout study conduct.
Step-by-step
Six stages from first inquiry to study close-out.
Initial inquiry
Inquiry: Sponsor submits a feasibility request. It routes directly to ARI's medical and operations leadership for review.
Feasibility assessment
First pass: Patient access, site capability, and investigator availability shape the preliminary feasibility response.
Budget and contract
In parallel: Budget development, transparent pricing, and contract execution move alongside startup preparation.
Site activation
2-4 weeks typical: IRB or ethics submission, investigator training, system access setup, and supply verification prepare sites for enrollment.
Enrollment and conduct
During study conduct: Protocol-compliant visits, data entry, enrollment reporting, and ongoing sponsor communication.
Close-out
Post-last-patient-visit: Database lock support, document archival, reconciliation, and audit-ready study file delivery.
What sponsors can expect
Speed, visibility, and documentation discipline at every stage.
Leadership-direct review
Sponsor inquiries route directly to ARI's medical and operations leadership, not a generic intake queue.
Decision-ready first pass
The first feasibility response includes patient access, site-capability context, and investigator availability.
2–4 week typical startup window
Structured activation with defined milestones, from IRB submission through enrollment readiness.
Operating discipline
Sponsors evaluate risk as much as speed. ARI's process addresses both.
Protocol compliance
Protocol-compliant study conduct and documentation discipline maintained across all sites.
IRB and ethics workflow
Regulatory submissions, staff training, and ethics oversight are treated as milestones, not assumptions.
Reporting and communication
Regular sponsor updates, enrollment reporting, and issue management throughout study conduct.
Audit-ready close-out
Document archival, reconciliation, and a clean study file complete every engagement.